Almas Qudrat is our Chief Quality Officer. In this role, Ms. Qudrat is responsible for leading all quality functions at Kodiak. Ms. Qudrat joined the company in 2018 and has more than 25 years of experience in managing and directing all aspects of quality activities for biotechnology and pharmaceutical companies. Her experience spans all stages of drug development from first in human to commercial products. She has been responsible for small molecules, biologics, tablets, capsules, pre-filled syringes, vials, and combination products via intravenous, subcutaneous, intravitreal, inhalable, as well as transdermal routes of administration. Ms. Qudrat’s experience spans good manufacturing practice (GMP), good clinical practice (GCP) and good laboratory practice (GLP). She has managed in-house quality functions as well as overseeing and managing external contract manufacturing and research organizations. Ms. Qudrat led the pre-approval inspections that brought Botox (Allergan), Myoblock (Elan), and Exubera (Nektar-Pfizer) to the market and supported, prepared, and contributed to multiple pre-approval activities for other products including the Lucentis pre-filled syringe (Roche/Genentech). Before joining Kodiak, Ms. Qudrat held positions of increasing responsibility at Abbott, Baxter, Elan, Allergan, Nektar, Avidia, Amgen, Jazz Pharmaceuticals and Roche/Genentech. Ms. Qudrat earned masters degrees in both microbiology and biology from Brock University in Ontario, Canada.